The paper studied the rational for including of ursodeoxycholic acid suspension in complex therapy of atopic dermatitis for infants. The indication of ursodeoxycholic acid suspension for 25 infants with atopic dermatitis resulted in positive clinical dynamics of both dermic and gastrointestinal signs, that manifested as reduction of area of impaired skin, intensity of itch, sleep normalization and regression of pain abdominal syndrome, regurgitation.
atopic dermatit; infants; ursodeoxycholic acid
Aryayev NL, Kukushkin VN. Current concept of management of atopic dermatitis in children. Odes'kij medichnij zhurnal. 208;6(110):32-5. (In Russian).
Aryayev NL, Tsyunchyk YuG, Kukushkin VN. Clinical efficacy of prebiotics in children suffering from atopic dermatitis. Odes'kij medichnij zhurnal. 2008;2(106):20-6. (In Russian).
Aryayev NL, Shevcheko IM, Gornostaeva NYu. Clinical effect of Ursodeoxycholic acid in treatment of atopic dermatitis in children. Sovremennaja pediatrija. 2012;5:93-7. (In Russian).
Zaikov SV. Atopic dermatitis in children. Ditjachij lіkar. 2010;2:51-8. (In Ukrainian).
Kalyizhnaya LD. Atopic dermatitis. Current problems of diagnosis and treatment. Klіnіchna іmunologіja, alergologіja, іnfektologіja. 2006;1(02):19-22. (In Russian).
Kamasheva GR. Atopic dermatitis in infants: features of diagnosis and treatment. Rossijskij allergologicheskij zhurnal. 2008;1:126-7. (In Russian).
Korotky NG, Botkina AS. Atopic dermatitis in children: modern strategy and management. Trudnyj pacient. 2007;10”5-10. (In Russian).
Nadinskaya My. Study of Ursodeoxycholic acid in hepatology from evidence-based medicine. Consilium medicum. 2003;6:318-22. (In Russian).
Beuers U. Mechanisms of action of ursodeoxycholic acid. In: Falk Symposium 117. Hepatology, 2000. Kluwer Academic Publishers; 2001. pp. 83-9.
Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the Europian task force on atopic dermatitis. Dermatology 1993;186:23-31. PMID: 8435513.
Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders. J Hepatology. 2001;35:134-46. PMID: 11495032.
Shah SA, Arfin SQ, Latif MA, et al. Ursodeoxycholic acid inhibits deoxycholic acid and interleukin beta 1 induced NF-KB and AP1 activation in human colorectal cancer cells. Gut. 2003;52(VI):A22.
Fadia M, Arifhodzic N, Al-Awadh R, Heines D. Intrecellular cytokine production in children with atopic dermatitis: effect of levocetirizine treatment. Pediatrija danas. 2009;5:161-71.